NCT06520475View on ClinicalTrials.gov

Efficacy of Bupivacaine-magnesium Combination Versus Bupivacaine Alone in Genicular Nerve Block

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

March 31, 2025

Conditions
Post Operative Pain
Interventions
PROCEDURE

genicular nerve block using bupivacaine and magnesium

The patients will receive 13 ml of 0.5% bupivacaine and 2 ml of 10% magnesium sulfate

PROCEDURE

genicular nerve block using bupivacaine and normal saline

The patients will receive 13 ml of 0.5% bupivacaine and 2 ml of normal saline

All Listed Sponsors
lead

Cairo University

OTHER

NCT06520475 - Efficacy of Bupivacaine-magnesium Combination Versus Bupivacaine Alone in Genicular Nerve Block | Biotech Hunter | Biotech Hunter